EP Patent

EP0289204A2 — Lithium salt-containing pharmaceutical compositions

Assigned to Scarista Ltd · Expires 1988-11-02 · 38y expired

What this patent protects

The invention provides pharmaceutical and disinfectant compositions containing lithium salts of C₁₈₋₂₂ polyunsaturated fatty acids. The compositions may be used in the treatment of conditions responsive to lithium and/or polyunsaturated fatty acid therapy, in parenteral alimentat…

USPTO Abstract

The invention provides pharmaceutical and disinfectant compositions containing lithium salts of C₁₈₋₂₂ polyunsaturated fatty acids. The compositions may be used in the treatment of conditions responsive to lithium and/or polyunsaturated fatty acid therapy, in parenteral alimentation or food supplements or in surface disinfection to combat transmission of viral diseases.

Drugs covered by this patent

Patent Metadata

Patent number
EP0289204A2
Jurisdiction
EP
Classification
—
Expires
1988-11-02
Drug substance claim
No
Drug product claim
No
Assignee
Scarista Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.